Day: June 25, 2024

LOS ANGELES, June 25, 2024 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS), a leader in the electrification of fleets, is excited to announce the delivery of Xos SV Stepvans and comprehensive charging solutions to Morgan Services, a family-owned textile company. This delivery introduces Morgan Services to their first set of Class 6 battery-electric stepvans from Xos, with additional orders placed for their facilities in Los Angeles and San Diego.Dakota Semler, CEO and Co-Founder of Xos, Inc., expressed enthusiasm about the partnership, stating, “It’s an honor to welcome Morgan Services as one of our valued customers. Adding Morgan Services to our growing list of Linen & Uniform Companies is a testament to our stepvan being the perfect solution to this industry’s electrification needs.” Xos Energy Solutions also set up nine...

NurseMagic™‘s NurseNotes Tool Creates Nursing Reports in Seconds – for Functions that Presently Consume Up to 40% of Nurses’ Time DETROIT, June 25, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced that its NurseMagic™ app now has the capability to create nursing notes which are required, for professionals ranging from CNAs and LPNs to APRN-CNPs and NPs. Notes can be created in various formats including SOAP, PIE and DAR, speeding up the creation of required patient record documentation for all nurses. The app has experienced rapid adoption by nurses following its release to the general public, and utilizes Amesite’s proprietary technology to provide useful information and assistance...

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, June 25, 2024 (GLOBE NEWSWIRE) — 79North Inc. (CSE: JQ) (“79North” or the “Company”) announces that it will enter into a series of debt settlement agreements (the “Settlement Agreements”) for the issuance of 1,960,900 common shares in the capital of the Company (the “Shares”) at a deemed price of $0.025 per Share to certain creditors of the Company (the “Creditors”) for settlement of debts owing to the Creditors in an aggregate amount of $49,022.60 pursuant to the previously announced demand promissory notes entered into between the Company and the Creditors (the “Shares for Debt Settlement”). All securities to be issued in the Shares for Debt Settlement will be subject to a hold period of four months and one day from the date of issuance, under...

VANCOUVER, British Columbia, June 25, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF) announces that pursuant to the Company’s stock option plan, on June 25, 2024 it granted stock options exercisable into 3,520,000 common shares in the Company to certain directors, officers, employees, and consultants of the Company. The stock options are exercisable at a price of C$1.18 per share for a five-year term. About Fireweed Metals Corp. (TSXV: FWZ; OTCQX: FWEDF; FSE:M0G): Fireweed Metals Corp. is an exploration company unlocking significant value in a new critical metals district located in Yukon, Canada. Fireweed is 100% owner of the Macpass District, a large and highly prospective 977 km2 land package. The Macpass District includes the Macpass zinc-lead-silver project and the Mactung...

Rahsaan W. Thompson appointed as Chief Legal Officer, Secretary and Compliance Officer Alison Peters appointed as Chief People Officer CELEBRATION, Fla., June 25, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the appointments of Rahsaan W. Thompson as Chief Legal Officer, Secretary and Compliance Officer, and Alison Peters as Chief People Officer. Both Mr. Thompson and Ms. Peters bring deep expertise in building high-performing teams which will be essential to deliver success through the Company’s next phase of growth. “We are thrilled to welcome both Rahsaan and Alison to the Zevra team as we continue the expansion and progress of our rare disease portfolio,” said Neil F. McFarlane, President and Chief Executive Officer of Zevra....

Greenfield manufacturing and R&D facility in Nottingham, U.K. to open in early 2025ABB invests in state-of-the-art earthing and lightning protection factory in Nottingham, United KingdomNew greenfield facility, set to open in early 2025, will significantly boost production of ABB’s Furse® solutions in over 20 countries.ZURICH, SWITZERLAND, June 25, 2024 (GLOBE NEWSWIRE) —Technologically advanced factory will increase production of Furse® earthing and lightning protection solutions, used in more than 20 countries Expands ABB’s manufacturing capabilities in Europe to help meet demand for electrical protection systems that safeguard buildings, wind turbines, data centers and critical infrastructure  Lightning strikes and electrical surges disrupt critical operations and cause billions of dollars in damage...

FREMONT, Calif., June 25, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it has signed an agreement with a leading California-based technology company to provide silicon batteries and packs for a mixed reality headset. Under the terms of the agreement, Enovix will receive an immediate one-time payment for tooling to support battery pack dimensions followed by payments for the delivery of both sample and production quantities. “We are thrilled to sign this agreement with a clear leader in the mixed reality market,” said Samira Naraghi, Senior Vice President, Product, Enovix. “Devices in this market need to be light, fashionable, and safe while also supporting ‘always-on’ immersive experiences that leverage AI. Our high energy density batteries are...

Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant huntingtin (mHTT) protein compared to placebo, preservation of wild-type huntingtin (wtHTT) protein, and generally safe and well-tolerated profile achieved in 30 mg multidose cohort Statistically significant correlation between mHTT lowering and slowing of caudate atrophy – an imaging biomarker predictive of clinical outcomes Wave to engage regulators on a clinical development path for WVE-003 that would support a potential accelerated approval, and will submit its opt-in package to program partner Takeda Data provide further validation for Wave’s RNA medicines platform, including PN chemistry, and pipeline; Wave remains on track to deliver 6-month dystrophin data for WVE-N531 in DMD in 3Q 2024 and RNA editing proof-of-mechanism...

– Successfully Established Favorable Tolerability and Safety of OLC – – New Drug Application (NDA) Submission Anticipated in Q3 2024 – – Webcast and Conference Call Today at 8:30 A.M. ET – LOS ALTOS, Calif., June 25, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced positive results from the Oxylanthanum Carbonate (OLC) UNI-OLC-201 pivotal clinical trial with regard to both safety and tolerability endpoints. OLC is a next-generation lanthanum-based phosphate binding agent utilizing proprietary nanoparticle technology being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD). The study established promising tolerability of OLC at...